[ACRS] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -12.00%
YoY- -77.38%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 2,398 17,570 9,282 1,869 2,528 7,753 19,018 -74.82%
PBT -16,941 -1,858 -29,261 -29,569 -28,160 -27,635 -19,952 -10.32%
Tax 200 -367 -219 -1,500 -1,758 5,656 1,278 -70.92%
NP -16,941 -1,491 -29,261 -29,569 -26,402 -33,291 -21,230 -13.95%
Tax Rate - - - - - - - -
Total Cost 19,339 19,061 38,543 31,438 28,930 41,044 40,248 -38.62%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -706.46 -8.49 -315.24 -1,582.08 -1,044.38 -429.40 -111.63 241.75%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.24 -0.02 -0.41 -0.42 -0.39 -0.50 -0.32 -17.43%
EPS Diluted -0.24 -0.02 -0.41 -0.42 -0.39 -0.50 -0.32 -17.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.